article thumbnail

STAT+: Medicare taps acting official to head up its new drug price negotiations

STAT

WASHINGTON — Medicare has chosen a Center for Medicare and Medicaid Innovation official to temporarily lead its implementation of Democrats’ drug pricing law, a document obtained by STAT shows.

article thumbnail

STAT+: Generic GLP-1 drugs could help Medicare drive a harder bargain for Ozempic and Wegovy

STAT

The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide , according to experts familiar with the price-negotiation program and STAT’s review of documents from the first round of negotiations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Tennessee officials find Express Scripts violated law governing commercial pharmacy claims

STAT

In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest pharmacy benefit managers in the United States, violated state laws in its dealings with pharmacies, according to newly released documents.

article thumbnail

STAT+: Canada advances an antitrust probe into Express Scripts over ‘patient steering’ and pharmacy fees

STAT

Canadian officials have obtained a court order that requires Express Scripts to produce documents in connection with an investigation into whether the pharmacy benefits manager violated antitrust laws. The Competition Bureau is examining whether the company forced or induced Canadians to use its own pharmacies.

article thumbnail

STAT+: Hospitals earn big profits, insurers face ramped up Medicare Advantage audits

STAT

We’ll be talking about all things Medicare Advantage. Details here on how to watch or attend!

Hospitals 243
article thumbnail

STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug ‘rebate credit’

STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies. Continue to STAT+ to read the full story…

article thumbnail

STAT+: Nostrum Laboratories and its CEO — who once defended Shkreli price hikes — to pay up to $50 million over Medicaid rebates

STAT

A pharmaceutical company and its chief executive — who once defended Martin Shkreli for raising drug prices to controversial heights — agreed to pay up to $50 million to settle allegations of purposely underpaying Medicaid rebates.